Picture of Roebuck Food logo

RFG Roebuck Food News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesAdventurousMicro CapMomentum Trap

Interim Results 2021

RNS Number : 4650H

Norish PLC

04 August 2021

 

 

Norish plc

Interim Results 2021

Results

 

Norish plc (AIM: NSH), is pleased to announce its interim results for the six months ended 30 June 2021.

 

Financial Highlights

·    Sales increased by 19%, from £15.9m to £18.9m.

·    Operating profit increased by 61%, from £0.94m to £1.51m.

·    Pre-tax profit increased by 73%, from £0.78m to £1.35m.

·    Fully diluted adjusted Eps increased by 74%, from 2.06p to 3.58p.

·    Interest cover stood at 9.9x, at the half year stage.

·    Net debt increased from £8.7m at December 2020 to £9.5m.

 

Divisional Highlights

 

£'mCold StoreSourcingDairy
Jun-21
£'000
Jun-20
£'000
% GrowthJun-21
£'000
Jun-20
£'000
% GrowthJun-21
£'000
Jun-20
£'000
% Growth
Revenue7,9387,08312%10,4798,41325%50839927%
Operating Profit1,7551,37428%12110120%32(143)
Operating Margin22.1%19.4%1.2%1.2%6.3%(36%)
    Cold Stores   Sales in the temperature-controlled division increased 12%, (+7% excluding Blast Freezing), from £7.1m to £7.9m. Costs increased by 8%, with power up 10% and employee costs up 3%. Operating profits increased by 28% from £1.4m to £1.8m and operating margins improved, from 19.4% to 22.1%. EBITDA increased by 21% from £2.25m to £2.72m in the period under review.   At an operational level, pallets inbound were ahead by 9%, on the same period in the prior year while blast freezing volumes were ahead 32% on the same period. Occupancy was largely unchanged at 89% (90% in the first half of 2020). Stock turn improved from 8.2 weeks on average in H1 2020 to 7.6 weeks in H1 2021.   Sourcing Division   Sales at our sourcing division increased by 25%, compared with the same period in 2020, from £8.4m to £10.5m. Operating profit improved from £101,000 to £121,000.   Our product sourcing division was impacted by Covid-19 and Brexit in the first quarter of 2021. We have seen a strong recovery in the second quarter with the development of a protein export business to South Africa.     Dairy Division Our subsidiary, Grass to Milk Company Ltd, continues to make progress; commercialising A2 protein, grass-fed, dairy products.   We are pleased to announce an exciting collaboration with Bright Dairy & Food Co Ltd and New Zealand Focus Group, jointly developing a new ultra-premium, A2-protein, grass-fed, Pure Milk UHT product for China, which will go on sale in the second half of the year.   Our operations team completed the development of a robust supply chain and quality system in the first half of 2021, which will act as a future growth platform; we were recently awarded an AA BRC audit score for Grass to Milk Ltd . Management built out a commercial team on the ground in China and are expanding into high growth retail channels such as Social Commerce, E-Commerce and High-End Retail.   Cantwellscourt Farm Ltd is providing A2 protein milk supply to Grass to Milk Ltd, in the first instance. Cantwellscourt Farm continues to improve operationally across key operating KPI's. Milk production was 18% ahead year on year. Profits improved substantially from a loss of £143,000 in half one 2020, to a profit of £32,000 in the first half of 2021.   Outlook   We remain optimistic for continued growth in profitability at Norish Cold Stores for the balance of the year. Group occupancy at this juncture (at 85%) is 9% higher than the same time last year.   We are happy with the significant progress made with the development of our A2 protein milk supply via Cantwellscourt Farm. Grass to Milk Company will deliver its first sale in the second half of the year.   Our protein sourcing division is expected to have a strong second half to the year as markets continue to normalise.   Strategic Review   We announced in March 2021 that we would carry out a strategic review of our cold store operations. This process continues and we will provide an update in due course.   Dividend   The board does not recommend the payment of an interim dividend, unchanged from last year.   Net Debt   Net debt (post IFRS 16) increased to £9.5m at end June 2021, from £8.7m in December 2020. The increase in net debt reflects additional working capital requirements and ongoing investment. Cash generated from operations amounted to £1.3m. Investment of £1.9m was made in assets, comprising £0.7m in Grass to Milk and £1.2m in equipment at the cold store division.      
Norish plc
Consolidated income statement
For the six months ended 30 June 2021
Six monthsSix monthsYear
endedendedended
30 June30 June31 December
202120202020
(Unaudited)(Unaudited)(Audited)
£'000£'000£'000
Continuing operations
Revenue18,92515,89533,361
Cost of sales(17,130)(14,659)(30,389)
Gross profit1,7951,2362,972
Other income11388182
Administrative expenses(402)(388)(865)
Operating profit from continuing operations1,5069362,289
Finance income - interest receivable--1
Finance expenses - lease interest(87)(94)(117)
Finance expenses - interest on bank loans(65)(63)(196)
Profit on continuing activities before taxation1,3547791,977
Income taxes - Corporation tax(277)(160)(224)
Income taxes - Deferred tax--(245)
Profit for the period attributable to owners of the parent from continuing operations1,0776191,508
Loss from discontinued activities(69)-(71)
Profit for the period1,0086191437
Other comprehensive income(228)-162
Total comprehensive income for the year7806191,599
Earnings per share expressed in pence per share:
From continuing operations
- basic
3.58p2.06p5.02p
- diluted3.58p2.06p5.02p
From discontinued operations
- basic
(0.23)p0p(0.24)p
- diluted(0.23)p0p(0.24)p
Norish plc
Interim balance sheet
As at 30 June 2021
As atAs atAs at
30 June30 June31 December
202120202020
(Unaudited)(Restated)(Audited)
£'000£'000£'000
ASSETS
Non-current assets
Goodwill2,3382,3382,338
Intangible assets1,9068071,269
Biological assets856700770
Property, plant and equipment22,96022,59222,898
28,06026,43727,275
Current assets
Trade and other receivables8,4944,8387,526
Inventories1571,02558
Cash and cash equivalents8431,5011,550
Assets of disposal group classified as held for sale270277381
9,7647,6419,515
TOTAL ASSETS37,82434,07836,790
Equity attributable to equity holders of the parent
And non-controlling interest
Share capital5,6405,6405,640
Share premium account7,3217,3217,321
Other reserves(87)(21)141
Retained earnings6,7584,9325,750
TOTAL EQUITY19,63217,87218,852
Non-current liabilities
Borrowings5,0525,7575,514
Deferred tax1,2441,0021,244
6,2966,7596,758
Current liabilities
Trade and other payables6,1195,5266,288
Current tax liabilities450442151
Borrowings5,3273,4794,741
11,8969,44711,180
TOTAL EQUITY AND LIABILITIES37,82434,07836,790
Norish plc
Consolidated statement of changes in equity
For the six months ended 30 June 2021
ShareShareOtherTreasuryRetained
capitalpremiumReservessharesearningsTotal
£'000£'000£'000£'000£'000£'000
At 1 January 20205,6407,321(21)-4,31317,253
Net profit for the financial period---619619
Total comprehensive income for the period----619619
Issue of share capital------
Equity dividends paid (recognised directly in equity)------
Transactions with owners----619619
At 30 June 20205,6407,321(21)-4,93217,872
Net profit/(loss) for the financial period---818818
Total comprehensive income for the period---818818
Issue of share capital------
Equity dividends paid (recognised directly in equity)-----
Foreign Exchange gain--162--162
Transactions with owners--162-818980
At 31 December 20205,6407,321141-5,75018,852
 
Net profit for the financial period----1,0081,008
Total comprehensive income for the period----1,0081,008
Issue of share capital------
Equity dividends paid (recognised directly in equity)------
Foreign Exchange loss--(228)--(228)
Transactions with owners--(228)-1,008780
At 30 June 20215,6407,321(87)-6,75819,632
           
Norish plc
Consolidated cash flow statement
For the six months ended 30 June 2021
Six monthsSix monthsYear
EndedendedEnded
30 June30 June31 December
202120202020
(Unaudited)(Restated)(Restated)
£'000£'000£'000
Profit on continuing activities before taxation1,3547791,977
Gain on biological assets(113)(88)(182)
Foreign exchange loss/(gain)205(51)(55)
Loss on discontinued activities(69)-(71)
Finance expenses152157316
Finance income--(1)
Depreciation - property, plant and equipment9878871,789
2,5161,6843,773
Changes in working capital:
(Increase)/decrease in inventories(99)801,047
(Increase)/decrease in trade and other receivables(968)2,019(669)
Increase/(decrease) in trade and other receivables for disposal111-(104)
Increase/(decrease) in current liabilities held for sale---
Decrease in payables(169)(1,038)(276)
Cash generated from operations1,3912,7453,771
Interest paid(152)(157)(316)
Interest received--1
Taxation refund/(paid)2251(304)
Net cash from operating activities1,2612,6393,152
Investing activities
Investment in intangible assets(685)(243)(705)
Purchase of biological assets(10)(5)(65)
Sale of biological assets8268346
Purchase of property, plant and equipment(1,177)(634)(1,741)
Net cash used in investing activities(1,864)(614)(2,165)
Financing activities
Dividends paid to shareholders---
Invoice finance receipts/ (payments)475(1,225)(150)
Finance lease capital repayments(623)(405)(845)
Finance lease advance258215882
Term loan advance---
Term loan repayments(214)(163)(378)
Net cash used in financing activities(104)(1,578)(491)
Net (decrease)/increase in cash and cash equivalents(707)447496
Cash and cash equivalents, at beginning of period1,5501,0541,054
Cash and cash equivalents end of period8431,5011,550
  Note: The accounting policies applied throughout the period are consistent with those applied for the year ended 31 December 2020, as set out in the 2020 Annual Report.         Enquiries:
Norish
Aidan Hughes, Finance DirectorTelephone: + 44 1293 862 498
Davy
Anthony FarrellTelephone: + 353 1 679 6363
  This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     IR PJMATMTIMBIB

Recent news on Roebuck Food

See all news